MENU
HQY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

HQY stock forecast, quote, news & analysis

HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions... Show more

A.I.Advisor
published price charts
HQY
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for HQY with price predictions
Oct 05, 2026

HQY in upward trend: price may ascend as a result of having broken its lower Bollinger Band on September 23, 2026

HQY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 27 of 32 cases where HQY's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where HQY's RSI Oscillator exited the oversold zone, 19 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 37 of 55 cases where HQY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 67%.

The Moving Average Convergence Divergence (MACD) for HQY just turned positive on October 05, 2026. Looking at past instances where HQY's MACD turned positive, the stock continued to rise in 39 of 50 cases over the following month. The odds of a continued upward trend are 78%.

Following a +2.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where HQY advanced for three days, in 227 of 309 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HQY as a result. In 52 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 58%.

The 10-day moving average for HQY crossed bearishly below the 50-day moving average on September 04, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 75%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HQY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.

The Aroon Indicator for HQY entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating fairly steady price growth. HQY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 61 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock slightly better than average.

The Tickeron SMR rating for this company is 66 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.676) is normal, around the industry mean (7.432). P/E Ratio (31.935) is within average values for comparable stocks, (46.656). Projected Growth (PEG Ratio) (1.287) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (6.035) is also within normal values, averaging (6.065).

The Tickeron PE Growth Rating for this company is 87 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Teladoc Health (NYSE:TDOC).

Industry description

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

Market Cap

The average market capitalization across the Services to the Health Industry Industry is 2.95B. The market cap for tickers in the group ranges from 708 to 45.33B. VEEV holds the highest valuation in this group at 45.33B. The lowest valued company is OTRKQ at 708.

High and low price notable news

The average weekly price growth across all stocks in the Services to the Health Industry Industry was 4%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 30%. BEAT experienced the highest price growth at 75%, while ONMD experienced the biggest fall at -19%.

Volume

The average weekly volume growth across all stocks in the Services to the Health Industry Industry was 707%. For the same stocks of the Industry, the average monthly volume growth was 970% and the average quarterly volume growth was 449%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 74
Price Growth Rating: 53
SMR Rating: 86
Profit Risk Rating: 97
Seasonality Score: 3 (-100 ... +100)
View a ticker or compare two or three
HQY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a provider of solutions for managing health care accounts

Industry ServicestotheHealthIndustry

Industry
Investment Managers
Address
15 West Scenic Pointe Drive
Phone
+1 801 727-1000
Employees
2814
Web
https://www.healthequity.com
HQY in upward trend: price may ascend as a result of having broken its lower Bollinger Band on September 23, 2026